Cargando…
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Autores principales: | Richardson, Peter, Griffin, Ivan, Tucker, Catherine, Smith, Dan, Oechsle, Olly, Phelan, Anne, Rawling, Michael, Savory, Edward, Stebbing, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137985/ https://www.ncbi.nlm.nih.gov/pubmed/32032529 http://dx.doi.org/10.1016/S0140-6736(20)30304-4 |
Ejemplares similares
-
COVID-19: combining antiviral and anti-inflammatory treatments
por: Stebbing, Justin, et al.
Publicado: (2020) -
Expert-Augmented Computational Drug Repurposing Identified Baricitinib as a Treatment for COVID-19
por: Smith, Daniel P., et al.
Publicado: (2021) -
Baricitinib as the treatment of choice for hospitalised individuals with COVID-19
por: Richardson, Peter J., et al.
Publicado: (2022) -
Baricitinib for COVID-19: a suitable treatment? – Authors' reply
por: Richardson, Peter J, et al.
Publicado: (2020) -
The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19
por: Richardson, Peter J., et al.
Publicado: (2022)